Sustained Remission of New-onset Heart Failure in Genetic Cardiomyopathy Without Contemporary Four-pillar Therapy: Implications for ‘Personalized Guideline-directed Medical Therapy’
US Cardiology Review · 06.11.2026
DOI: 10.15420/usc.2026.26 ↗Kurz gefasst
Leitlinie in der Zeitschrift US Cardiology Review, online erschienen am 06.11.2026. Verfasst von Chinanuekpere Emma Ezeala und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
A 40-year-old woman with new-onset heart failure with reduced ejection fraction (HFrEF) attributed to a titin-truncating variant achieved remission while being treated with carvedilol, lisinopril (first 4 years), and losartan (for 1 year following lisinopril cessation). The patient never received an angiotensin receptor–neprilysin inhibitor, mineralocorticoid receptor antagonist, or sodium–glucose cotransporter 2 inhibitor. Her left ventricular ejection fraction rose from 50%, her N-terminal pro-B-type natriuretic peptide level dropped from 1,980 pg/ml to 79 pg/ml, and she regained New York Heart Association I status. Her remission persists more than a decade after condition onset. This case demonstrates that patients with genetic cardiomyopathy can achieve durable remission with a narrower set of medications than quadruple therapy.
Zitieren
APA
Ezeala, C. E., Pitonak, M., Munch, J., Thibodeau, J. T., & Drazner, M. H. (2026). Sustained Remission of New-onset Heart Failure in Genetic Cardiomyopathy Without Contemporary Four-pillar Therapy: Implications for ‘Personalized Guideline-directed Medical Therapy’. US Cardiology Review. https://doi.org/10.15420/usc.2026.26
Vancouver
Ezeala CE, Pitonak M, Munch J, Thibodeau JT, Drazner MH. Sustained Remission of New-onset Heart Failure in Genetic Cardiomyopathy Without Contemporary Four-pillar Therapy: Implications for ‘Personalized Guideline-directed Medical Therapy’. US Cardiology Review. 2026. doi:10.15420/usc.2026.26
BibTeX
@article{Ezeala2026,
author = {Ezeala, Chinanuekpere Emma and Pitonak, Michael and Munch, Jake and Thibodeau, Jennifer T and Drazner, Mark H},
title = {Sustained Remission of New-onset Heart Failure in Genetic Cardiomyopathy Without Contemporary Four-pillar Therapy: Implications for ‘Personalized Guideline-directed Medical Therapy’},
journal = {US Cardiology Review},
year = {2026},
doi = {10.15420/usc.2026.26}
}
EUVIMED